Repository logo
 
No Thumbnail Available
Publication

Betulinic acid for glioblastoma treatment: Reality, challenges and perspectives

Use this identifier to reference this record.
Name:Description:Size:Format: 
ART_Ricardo Ferraz.pdf1.35 MBAdobe PDF Download

Advisor(s)

Abstract(s)

Betulinic acid is a naturally occurring compound that can be obtained through methanolic or ethanolic extraction from plant sources, as well as through chemical synthesis or microbial biotransformation. Betulinic acid has been investigated for its potential therapeutic properties, and exhibits anti-inflammatory, antiviral, antimalarial, and antioxidant activities. Notably, its ability to cross the blood–brain barrier addresses a significant challenge in treating neurological pathologies. This review aims to compile information about the impact of betulinic acid as an antitumor agent, particularly in the context of glioblastoma. Importantly, betulinic acid demonstrates selective antitumor activity against glioblastoma cells by inhibiting proliferation and inducing apoptosis, consistent with observations in other cancer types. Compelling evidence published highlights the acid’s therapeutic action in suppressing the Akt/NFκB-p65 signaling cascade and enhancing the cytotoxic effects of the chemotherapeutic agent temozolomide. Interesting findings with betulinic acid also suggest a focus on researching the reduction of glioblastoma’s invasiveness and aggressiveness profile. This involves modulation of extracellular matrix components, remodeling of the cytoskeleton, and secretion of proteolytic proteins. Drawing from a comprehensive review, we conclude that betulinic acid formulations as nanoparticles and/or ionic liquids are promising drug delivery approaches with the potential for translation into clinical applications for the treatment and management of glioblastoma.

Description

Keywords

Betulinic acid Glioblastoma Apoptosis Invasiveness Blood–brain barrier Drug delivery

Pedagogical Context

Citation

Fernandes, S., Vieira, M., Prudêncio, C., & Ferraz, R. (2024). Betulinic acid for glioblastoma treatment: Reality, challenges and perspectives. International Journal of Molecular Sciences, 25(4), 2108. https://doi.org/10.3390/ijms25042108

Research Projects

Organizational Units

Journal Issue